{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:37:34Z","timestamp":1792093054953,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"DOI":"10.7759\/cureus.12420","type":"journal-article","created":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T18:02:56Z","timestamp":1609524176000},"source":"Crossref","is-referenced-by-count":54,"title":["Disorders of Calcium Metabolism: Hypocalcemia and Hypercalcemia"],"prefix":"10.7759","author":[{"given":"Mohammad","family":"Tinawi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05910809","article-title":"Calcium metabolism in health and disease","volume":"5","author":"Peacock M","year":"2010","unstructured":"Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010, 5:S23-30. 10.2215\/CJN.05910809","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09750913","article-title":"Renal control of calcium, phosphate, and magnesium homeostasis","volume":"10","author":"Blaine J","year":"2015","unstructured":"Blaine J, Chonchol M, Levi M. Renal control of calcium, phosphate, and magnesium homeostasis. Clin J Am Soc Nephrol. 2015, 10:1257-72. 10.2215\/CJN.09750913","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007040449","article-title":"Pitfalls of measuring total blood calcium in patients with CKD","volume":"19","author":"Gauci C","year":"2008","unstructured":"Gauci C, Moranne O, Fouqueray B, et al.. Pitfalls of measuring total blood calcium in patients with CKD. J Am Soc Nephrol. 2008, 19:1592-8. 10.1681\/ASN.2007040449","journal-title":"J Am Soc Nephrol"},{"key":"ref4","article-title":"Disorders of calcium, magnesium, and phosphate balance","author":"Chonchol M","year":"2019","unstructured":"Chonchol M, Smogorzewski M, Stubbs J, Yu AS. Disorders of calcium, magnesium, and phosphate balance. Brenner & Rector's The Kidney. Yu AS, Chertow GM, Luyckx VA, Marsden PA, Skorecki K, Taal M (ed): Elsevier Inc, Philadelphia, PA; 2019. 11:613."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000116623","article-title":"Minireview on regulation of intestinal calcium absorption. Emphasis on molecular mechanisms of transcellular pathway","volume":"77","author":"P\u00e9rez AV","year":"2008","unstructured":"P\u00e9rez AV, Picotto G, Carpentieri AR, Rivoira MA, Peralta L\u00f3pez ME, Tolosa de Talamoni NG. Minireview on regulation of intestinal calcium absorption. Emphasis on molecular mechanisms of transcellular pathway. Digestion. 2008, 77:22-34. 10.1159\/000116623","journal-title":"Digestion"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4020-6191-2_6","article-title":"The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics","volume":"45","author":"Brown EM","year":"2007","unstructured":"Brown EM. The calcium-sensing receptor: physiology, pathophysiology and CaR-based therapeutics. Subcell Biochem. 2007, 45:139-67. 10.1007\/978-1-4020-6191-2_6","journal-title":"Subcell Biochem"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.04.023","article-title":"Acquired hypocalciuric hypercalcemia in a patient with CKD","volume":"62","author":"Kuo E","year":"2013","unstructured":"Kuo E, Kemp EH, Sandhu HK, Brown EM, Weetman AP, Huang CL. Acquired hypocalciuric hypercalcemia in a patient with CKD. Am J Kidney Dis. 2013, 62:1151-4. 10.1053\/j.ajkd.2013.04.023","journal-title":"Am J Kidney Dis"},{"key":"ref8","article-title":"Disorders of calcium, phosphate, and magnesium metabolism","author":"Kestenbaum B","year":"2018","unstructured":"Kestenbaum B, Houillier P. Disorders of calcium, phosphate, and magnesium metabolism. Comprehensive Clinical Nephrology. Johnson R, Feehally J, Floege J, Tonelli M (ed): Elsevier Inc, Philadelphia, PA; 2018. 6:124-41."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00608.2009","article-title":"Physiology and pathophysiology of the calcium-sensing receptor in the kidney","volume":"298","author":"Riccardi D","year":"2010","unstructured":"Riccardi D, Brown EM. Physiology and pathophysiology of the calcium-sensing receptor in the kidney. Am J Physiol Renal Physiol. 2010, 298:F485-99. 10.1152\/ajprenal.00608.2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1085\/jgp.200810154","article-title":"Molecular basis for cation selectivity in claudin-2-based paracellular pores: identification of an electrostatic interaction site","volume":"133","author":"Yu AS","year":"2009","unstructured":"Yu AS, Cheng MH, Angelow S, et al.. Molecular basis for cation selectivity in claudin-2-based paracellular pores: identification of an electrostatic interaction site. J Gen Physiol. 2009, 133:111-27. 10.1085\/jgp.200810154","journal-title":"J Gen Physiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1616733114","article-title":"Parathyroid hormone controls paracellular Ca 2+ transport in the thick ascending limb by regulating the tight-junction protein Claudin14","volume":"114","author":"Sato T","year":"2017","unstructured":"Sato T, Courbebaisse M, Ide N, et al.. Parathyroid hormone controls paracellular Ca 2+ transport in the thick ascending limb by regulating the tight-junction protein Claudin14. Proc Natl Acad Sci U S A. 2017, 114:E3344-53. 10.1073\/pnas.1616733114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1139\/bcb-2014-0061","article-title":"Paracellular calcium transport across renal and intestinal epithelia","volume":"92","author":"Alexander RT","year":"2014","unstructured":"Alexander RT, Rievaj J, Dimke H. Paracellular calcium transport across renal and intestinal epithelia. Biochem Cell Biol. 2014, 92:467-80. 10.1139\/bcb-2014-0061","journal-title":"Biochem Cell Biol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1042\/CS20090086","article-title":"Hereditary tubular transport disorders: implications for renal handling of Ca2+ and Mg2+","volume":"118","author":"Dimke H","year":"2009","unstructured":"Dimke H, Hoenderop JG, Bindels RJ. Hereditary tubular transport disorders: implications for renal handling of Ca2+ and Mg2+. Clin Sci (Lond). 2009, 118:1-18. 10.1042\/CS20090086","journal-title":"Clin Sci (Lond)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.26502\/acbr.50170099","article-title":"Disorders of magnesium metabolism: hypomagnesemia and hypermagnesemia","volume":"4","author":"Tinawi M","year":"2020","unstructured":"Tinawi M. Disorders of magnesium metabolism: hypomagnesemia and hypermagnesemia. Arch Clin Biomed Res. 2020, 4:205-20. 10.26502\/acbr.50170099","journal-title":"Arch Clin Biomed Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010020186","article-title":"The regulation of parathyroid hormone secretion and synthesis","volume":"22","author":"Kumar R","year":"2011","unstructured":"Kumar R, Thompson JR. The regulation of parathyroid hormone secretion and synthesis. J Am Soc Nephrol. 2011, 22:216-24. 10.1681\/ASN.2010020186","journal-title":"J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007111194","article-title":"Clinical consequences and management of hypomagnesemia","volume":"20","author":"Martin KJ","year":"2009","unstructured":"Martin KJ, Gonz\u00e1lez EA, Slatopolsky E. Clinical consequences and management of hypomagnesemia. J Am Soc Nephrol. 2009, 20:2291-5. 10.1681\/ASN.2007111194","journal-title":"J Am Soc Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00014.2015","article-title":"Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects","volume":"96","author":"Christakos S","year":"2016","unstructured":"Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016, 96:365-408. 10.1152\/physrev.00014.2015","journal-title":"Physiol Rev"},{"key":"ref18","article-title":"A practical approach to hypercalcemia","volume":"67","author":"Carroll MF","year":"2003","unstructured":"Carroll MF, Schade DS. A practical approach to hypercalcemia. Am Fam Physician. 2003, 67:1959-66.","journal-title":"Am Fam Physician"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0115426507022003323","article-title":"Low serum total calcium concentration as a marker of low serum ionized calcium concentration in critically ill patients receiving specialized nutrition support","volume":"22","author":"Dickerson RN","year":"2007","unstructured":"Dickerson RN, Henry NY, Miller PL, Minard G, Brown RO. Low serum total calcium concentration as a marker of low serum ionized calcium concentration in critically ill patients receiving specialized nutrition support. Nutr Clin Pract. 2007, 22:323-8. 10.1177\/0115426507022003323","journal-title":"Nutr Clin Pract"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2015.04.059","article-title":"Hypoparathyroidism after total thyroidectomy: incidence and resolution","volume":"197","author":"Ritter K","year":"2015","unstructured":"Ritter K, Elfenbein D, Schneider DF, Chen H, Sippel RS. Hypoparathyroidism after total thyroidectomy: incidence and resolution. J Surg Res. 2015, 197:348-53. 10.1016\/j.jss.2015.04.059","journal-title":"J Surg Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.11.8016","article-title":"Activating mutations of the calcium-sensing receptor: management of hypocalcemia","volume":"86","author":"Lienhardt A","year":"2001","unstructured":"Lienhardt A, Bai M, Lagarde JP, et al.. Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab. 2001, 86:5313-23. 10.1210\/jcem.86.11.8016","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/cc12756","article-title":"Assessment and clinical course of hypocalcemia in critical illness","volume":"17","author":"Steele T","year":"2013","unstructured":"Steele T, Kolamunnage-Dona R, Downey C, Toh CH, Welters I. Assessment and clinical course of hypocalcemia in critical illness. Crit Care. 2013, 17:R106. 10.1186\/cc12756","journal-title":"Crit Care"},{"key":"ref23","article-title":"Hypocalcemia: updates in diagnosis and management for primary care","volume":"58","author":"Fong J","year":"2012","unstructured":"Fong J, Khan A. Hypocalcemia: updates in diagnosis and management for primary care. Can Fam Physician. 2012, 58:158-62.","journal-title":"Can Fam Physician"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2006.04.003","article-title":"Dermatologic manifestations of parathyroid-related disorders","volume":"24","author":"Fuleihan Gel-H","year":"2006","unstructured":"Fuleihan Gel-H, Rubeiz N. Dermatologic manifestations of parathyroid-related disorders. Clin Dermatol. 2006, 24:281-8. 10.1016\/j.clindermatol.2006.04.003","journal-title":"Clin Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39582.589433.BE","article-title":"Diagnosis and management of hypocalcaemia","volume":"336","author":"Cooper MS","year":"2008","unstructured":"Cooper MS, Gittoes NJ. Diagnosis and management of hypocalcaemia. BMJ. 2008, 336:1298-302. 10.1136\/bmj.39582.589433.BE","journal-title":"BMJ"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt M","year":"2013","unstructured":"Mannstadt M, Clarke BL, Vokes T, et al.. Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol. 2013, 1:275-83. 10.1016\/S2213-8587(13)70106-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.2016.006890","article-title":"Malignancy-related hypercalcemia in advanced solid tumors: survival outcomes","volume":"3","author":"Ramos REO","year":"2017","unstructured":"Ramos REO, Perez Mak M, Alves MFS, et al.. Malignancy-related hypercalcemia in advanced solid tumors: survival outcomes. J Glob Oncol. 2017, 3:728-33. 10.1200\/JGO.2016.006890","journal-title":"J Glob Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy054","article-title":"Hypercalcemia: etiology and management","volume":"33","author":"Renaghan AD","year":"2018","unstructured":"Renaghan AD, Rosner MH. Hypercalcemia: etiology and management. Nephrol Dial Transpl. 2018, 33:549-51. 10.1093\/ndt\/gfy054","journal-title":"Nephrol Dial Transpl"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21489","article-title":"Hypercalcemia and cancer: differential diagnosis and treatment","volume":"68","author":"Zagzag J","year":"2018","unstructured":"Zagzag J, Hu MI, Fisher SB, Perrier ND. Hypercalcemia and cancer: differential diagnosis and treatment. CA Cancer J Clin. 2018, 68:377-86. 10.3322\/caac.21489","journal-title":"CA Cancer J Clin"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)90220-w","article-title":"Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia","volume":"339","author":"Ratcliffe WA","year":"1992","unstructured":"Ratcliffe WA, Hutchesson AC, Bundred NJ, Ratcliffe JG. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcaemia. Lancet. 1992, 339:164-7. 10.1016\/0140-6736(92)90220-w","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02470312","article-title":"Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia","volume":"7","author":"Rosner MH","year":"2012","unstructured":"Rosner MH, Dalkin AC. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia. Clin J Am Soc Nephrol. 2012, 7:1722-9. 10.2215\/CJN.02470312","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01451005","article-title":"Milk alkali syndrome and the dynamics of calcium homeostasis","volume":"1","author":"Felsenfeld AJ","year":"2006","unstructured":"Felsenfeld AJ, Levine BS. Milk alkali syndrome and the dynamics of calcium homeostasis. Clin J Am Soc Nephrol. 2006, 1:641-54. 10.2215\/CJN.01451005","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3390\/nu5124880","article-title":"Calcium-alkali syndrome in the modern era","volume":"5","author":"Patel AM","year":"2013","unstructured":"Patel AM, Adeseun GA, Goldfarb S. Calcium-alkali syndrome in the modern era. Nutrients. 2013, 5:4880-93. 10.3390\/nu5124880","journal-title":"Nutrients"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-015-0673-3","article-title":"Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism","volume":"34","author":"Tuna MM","year":"2016","unstructured":"Tuna MM, \u00c7al\u0131\u015fkan M, \u00dcnal M, et al.. Normocalcemic hyperparathyroidism is associated with complications similar to those of hypercalcemic hyperparathyroidism. J Bone Miner Metab. 2016, 34:331-5. 10.1007\/s00774-015-0673-3","journal-title":"J Bone Miner Metab"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1369","article-title":"Hidden hypercalcemia and mortality risk in incident hemodialysis patients","volume":"101","author":"Obi Y","year":"2016","unstructured":"Obi Y, Mehrotra R, Rivara MB, et al.. Hidden hypercalcemia and mortality risk in incident hemodialysis patients. J Clin Endocrinol Metab. 2016, 101:2440-9. 10.1210\/jc.2016-1369","journal-title":"J Clin Endocrinol Metab"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3013","article-title":"Development and validation of a novel laboratory-specific correction equation for total serum calcium and its association with mortality among hemodialysis patients","volume":"32","author":"Obi Y","year":"2017","unstructured":"Obi Y, Nguyen DV, Streja E, et al.. Development and validation of a novel laboratory-specific correction equation for total serum calcium and its association with mortality among hemodialysis patients. J Bone Miner Res. 2017, 32:549-59. 10.1002\/jbmr.3013","journal-title":"J Bone Miner Res"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp042806","article-title":"Clinical practice. Hypercalcemia associated with cancer","volume":"352","author":"Stewart AF","year":"2005","unstructured":"Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005, 352:373-9. 10.1056\/NEJMcp042806","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-4-200808190-00007","article-title":"Narrative review: furosemide for hypercalcemia: an unproven yet common practice","volume":"149","author":"LeGrand SB","year":"2008","unstructured":"LeGrand SB, Leskuski D, Zama I. Narrative review: furosemide for hypercalcemia: an unproven yet common practice. Ann Intern Med. 2008, 149:259-63. 10.7326\/0003-4819-149-4-200808190-00007","journal-title":"Ann Intern Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.558","article-title":"Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials","volume":"19","author":"Major P","year":"2001","unstructured":"Major P, Lortholary A, Hon J, et al.. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol. 2001, 19:558-67. 10.1200\/JCO.2001.19.2.558","journal-title":"J Clin Oncol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02550508","article-title":"Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue","volume":"4","author":"Toussaint ND","year":"2009","unstructured":"Toussaint ND, Elder GJ, Kerr PG. Bisphosphonates in chronic kidney disease; balancing potential benefits and adverse effects on bone and soft tissue. Clin J Am Soc Nephrol. 2009, 4:221-33. 10.2215\/CJN.02550508","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2014.07.005","article-title":"Denosumab for the management of hypercalcemia of malignancy in patients with multiple myeloma and renal dysfunction","volume":"14","author":"Cicci JD","year":"2014","unstructured":"Cicci JD, Buie L, Bates J, van Deventer H. Denosumab for the management of hypercalcemia of malignancy in patients with multiple myeloma and renal dysfunction. Clin Lymphoma Myeloma Leuk. 2014, 14:e207-11. 10.1016\/j.clml.2014.07.005","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.qjmed.a067792","article-title":"Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3","volume":"53","author":"Sandler LM","year":"1984","unstructured":"Sandler LM, Winearls CG, Fraher LJ, Clemens TL, Smith R, O'Riordan JL. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. Q J Med. 1984, 53:165-80. 10.1093\/oxfordjournals.qjmed.a067792","journal-title":"Q J Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/BF01720717","article-title":"Calcium free hemodialysis: experience in the treatment of 33 patients with severe hypercalcemia","volume":"22","author":"Camus C","year":"1996","unstructured":"Camus C, Charasse C, Jouannic-Montier I, Seguin P, Tulzo YL, Bouget J, Thomas R. Calcium free hemodialysis: experience in the treatment of 33 patients with severe hypercalcemia. Intensive Care Med. 1996, 22:116-21. 10.1007\/BF01720717","journal-title":"Intensive Care Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1714213","article-title":"Primary hyperparathyroidism","volume":"379","author":"Insogna KL","year":"2018","unstructured":"Insogna KL. Primary hyperparathyroidism. N Engl J Med. 2018, 379:1050-9. 10.1056\/NEJMcp1714213","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian JP","year":"2014","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014, 99:3561-9. 10.1210\/jc.2014-1413","journal-title":"J Clin Endocrinol Metab"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock M","year":"2005","unstructured":"Peacock M, Bilezikian JP, Klassen PS, Guo MD, Turner SA, Shoback D. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2005, 90:135-41. 10.1210\/jc.2004-0842","journal-title":"J Clin Endocrinol Metab"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1472","article-title":"Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study","volume":"94","author":"Peacock M","year":"2009","unstructured":"Peacock M, Bolognese MA, Borofsky M, Scumpia S, Sterling LR, Cheng S, Shoback D. Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study. J Clin Endocrinol Metab. 2009, 94:4860-7. 10.1210\/jc.2009-1472","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/47852-disorders-of-calcium-metabolism-hypocalcemia-and-hypercalcemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:52Z","timestamp":1707506872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/47852-disorders-of-calcium-metabolism-hypocalcemia-and-hypercalcemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,1]]},"references-count":47,"URL":"https:\/\/doi.org\/10.7759\/cureus.12420","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,1]]}}}